Peregrine Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $604K | Sell |
2,759
-1,211
| -31% | -$265K | 0.02% | 269 |
|
|
2025
Q1 | $889K | Hold |
3,970
| – | – | 0.03% | 267 |
|
|
2024
Q4 | $1.3M | Hold |
3,970
| – | – | 0.04% | 258 |
|
|
2024
Q3 | $1.19M | Buy |
3,970
+1,050
| +36% | +$315K | 0.04% | 263 |
|
|
2024
Q2 | $962K | Hold |
2,920
| – | – | 0.03% | 273 |
|
|
2024
Q1 | $1.16M | Hold |
2,920
| – | – | 0.03% | 265 |
|
|
2023
Q4 | $1.03M | Sell |
2,920
-459
| -14% | -$162K | 0.03% | 261 |
|
|
2023
Q3 | $1.27M | Sell |
3,379
-859
| -20% | -$322K | 0.04% | 253 |
|
|
2023
Q2 | $1.62M | Buy |
4,238
+699
| +20% | +$267K | 0.04% | 252 |
|
|
2023
Q1 | $1.23M | Sell |
3,539
-1,150
| -25% | -$398K | 0.04% | 249 |
|
|
2022
Q4 | $1.1M | Hold |
4,689
| – | – | 0.03% | 260 |
|
|
2022
Q3 | $1.15M | Hold |
4,689
| – | – | 0.04% | 261 |
|
|
2022
Q2 | $1.42M | Hold |
4,689
| – | – | 0.04% | 258 |
|
|
2022
Q1 | $1.93M | Hold |
4,689
| – | – | 0.05% | 256 |
|
|
2021
Q4 | $2.2M | Hold |
4,689
| – | – | 0.04% | 255 |
|
|
2021
Q3 | $1.99M | Hold |
4,689
| – | – | 0.04% | 256 |
|
|
2021
Q2 | $1.68M | Hold |
4,689
| – | – | 0.03% | 264 |
|
|
2021
Q1 | $1.32M | Hold |
4,689
| – | – | 0.02% | 276 |
|
|
2020
Q4 | $1.33M | Buy |
+4,689
| New | +$1.33M | 0.03% | 267 |
|